[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
[(1R)-3-methyl-1-[[(2S)-1-oxo-2-[[oxo-(2-pyrazinyl)methyl]amino]-3-phenylpropyl]amino]butyl]boronic acid
[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazin-2-ylcarbonylamino)propanoyl]amino]butyl]boronic acid
179324-69-7
LDP-341
NSC-681239
AIDS-004352
AIDS004352
Boronic acid, [(1(R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE
LPD-341
PS 341
Pyz-Phe-boroLeu
NCI60_029010
Bortezomib (JAN/USAN)
D03150
Boronic acid, [1-[[1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl) amino]propyl]amino]-3-methylbutyl]-, L-(S)-
NSC681239
PROSCRIPT BORONIC ACID
PS-341
DPBA
LPD 341
Velcade (TN)